Related Experiment Video

Updated: May 15, 2026

Surgical Technique of the 3-Dimensional-printed Personalized Hip Implant for the Treatment of Canine Hip Dysplasia
08:40

Surgical Technique of the 3-Dimensional-printed Personalized Hip Implant for the Treatment of Canine Hip Dysplasia

Published on: April 19, 2024

Developmental Dysplasia of the Hip: Management from a Pediatrician Perspective

Anthony El Alam1, Joseph Mouawad1, Andrew Takchi2,3

  • 1Department of Orthopedic Surgery, Lebanese American University Medical Center-Rizk Hospital, Lebanese American University, School of Medicine, Beirut, Lebanon.

Clinical Medicine Insights. Pediatrics
|May 14, 2026
PubMed

Insights

Lebanese pediatricians show significant gaps in Developmental Dysplasia of the Hip (DDH) screening knowledge and practices. Improved training and neonatal screening are crucial for early detection and better patient outcomes.

Area of Science:

  • Pediatric Orthopedics
  • Public Health

Background:

  • Developmental Dysplasia of the Hip (DDH) is a prevalent congenital anomaly.
  • Early diagnosis of DDH is critical to avoid invasive treatments.

Purpose of the Study:

  • To evaluate Lebanese pediatricians' knowledge of DDH risk factors, screening, and treatment.
  • To compare current practices with international guidelines.
  • To propose improved screening recommendations for DDH in Lebanon.

Main Methods:

  • Cross-sectional descriptive study utilizing confidential questionnaires.
  • Data collected from 263 Lebanese pediatricians.
  • Analysis of responses using proportion tests.

Main Results:

  • A significant training gap in DDH screening was identified among Lebanese pediatricians.
  • Most pediatricians did not adhere to recommended screening guidelines.
  • Gaps noted in risk factor identification, physical exams, imaging, and treatment.

Conclusions:

  • Urgent need for improved education and training on DDH screening and management.
  • Implementing routine neonatal screening is essential to reduce delayed diagnoses.
  • Addressing these gaps will improve early detection and patient outcomes for DDH.
Abstract

Keywords:
developmental dysplasia of the hiphip developmentpediatric orthopedicsrisk factorsscreening and diagnosis

More Related Videos

In Vivo Quantification of Hip Arthrokinematics during Dynamic Weight-bearing Activities using Dual Fluoroscopy07:43

In Vivo Quantification of Hip Arthrokinematics during Dynamic Weight-bearing Activities using Dual Fluoroscopy

Published on: July 2, 2021

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve09:51

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve

Published on: September 7, 2022

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...